Richard Baker

Prof. Richard Baker


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Gait & Posture
Verified
Journal Article
Closed access
JMJennifer L. McGinley
Jennifer L. McGinley
RBRichard Baker
Richard Baker
RWRory Wolfe
Rory Wolfe
PMProfessor Meg Morris
Professor Meg Morris

1 October 2009 in Gait & Posture
Verified
Journal Article
Closed access
RBRichard Baker
Richard Baker
JMJennifer L. McGinley
Jennifer L. McGinley
MSMichael H. Schwartz
Michael H. Schwartz
SBSarah Beynon
Sarah Beynon
ARAdam Rozumalski
Adam Rozumalski
Oren TiroshOren Tirosh
Oren Tirosh

2 March 2006 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
RBRichard Baker
Richard Baker
Introduction: Brand's four reasons for clinical tests and his analysis of the characteristics of valid biomechanical tests for use in orthopaedics are taken as a basis for determining what methodologies are required for gait analysis in a clinical rehabilitation context. Measurement methods in clinical gait analysis: The state of the art of optical systems capable of measuring the positions of retro-reflective markers placed on the skin is sufficiently advanced that they are probably no longer a significant source of error in clinical gait analysis. Determining the anthropometry of the subject and compensating for soft tissue movement in relation to the under-lying bones are now the principal problems. Techniques for using functional tests to determine joint centres and axes of rotation are starting to be used successfully. Probably the last great challenge for optical systems is in using computational techniques to compensate for soft tissue measurements. In the long term future it is possible that direct imaging of bones and joints in three dimensions (using MRI or fluoroscopy) may replace marker based systems. Methods for interpreting gait analysis data: There is still not an accepted general theory of why we walk the way we do. In the absence of this, many explanations of walking address the mechanisms by which specific movements are achieved by particular muscles. A whole new methodology is developing to determine the functions of individual muscles. This needs further development and validation. A particular requirement is for subject specific models incorporating 3-dimensional imaging data of the musculo-skeletal anatomy with kinematic and kinetic data. Methods for understanding the effects of intervention: Clinical gait analysis is extremely limited if it does not allow clinicians to choose between alternative possible interventions or to predict outcomes. This can be achieved either by rigorously planned clinical trials or using theoretical models. The evidence base is generally poor partly because of the limited number of prospective clinical trials that have been completed and more such studies are essential. Very recent work has started to show the potential of using models of the mechanisms by which people with pathology walk in order to simulate different potential interventions. The development of these models offers considerable promise for new clinical applications of gait analysis.

1 January 2010 in Gait & Posture
Verified
Journal Article
Closed access
APAlana Peters
Alana Peters
BGBrook Galna
Brook Galna
Morgan SangeuxMorgan Sangeux
Morgan Sangeux
PMProfessor Meg Morris
Professor Meg Morris
RBRichard Baker
Richard Baker

1 May 2010 in Journal of Biomechanics
Verified
Journal Article
Closed access
MAMassoud Akbarshahi
Massoud Akbarshahi
ASAnthony Schache
Anthony Schache
JFJustin W. Fernandez
Justin W. Fernandez
RBRichard Baker
Richard Baker
SBScott Banks
Scott Banks
Marcus PandyMarcus Pandy
Marcus Pandy

1 April 2012 in Gait & Posture
Verified
Journal Article
Closed access
RBRichard Baker
Richard Baker
JMJennifer L. McGinley
Jennifer L. McGinley
MSMike Schwartz
Mike Schwartz
PTPam Thomason
Pam Thomason
JRJill Rodda
Jill Rodda
HGH. Kerr Graham
H. Kerr Graham